Source Citation
Appleton S, Poole P, Smith B, et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006(3):CD001104. https://pubmed.ncbi.nlm.nih.gov/16855959
Clinical Impact Ratings
GIM/FP/GP: 
Pulmonology: 
References
- 1 Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26. [PMID:
16424409 ] Google Scholar - 2 Vestbo J. The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J. 2004;24:206-10. [PMID:
15332386 ] Google Scholar - 3 Barr RG, Bourbeau J, Camargo CA, et al. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax. 2006;61:854-62. [PMID:
16844726 ] Google Scholar
Author, Article and Disclosure Information
Affiliations:
University of Miami, Miller School of Medicine, Miami, Florida, USA (S.S.)
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an AIMCC publication.